Cite
HARVARD Citation
Latta‐Mahieu, M. et al. (2018). Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models. Glia. 66 (3), pp. 492-504. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Latta‐Mahieu, M. et al. (2018). Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models. Glia. 66 (3), pp. 492-504. [Online].